Apimeds Pharmaceuticals US, Inc
Apimeds Pharmaceuticals US, Inc (APUS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · APUS · as of Jun 9, 2026
Key Statistics
Explore Apimeds Pharmaceuticals US, Inc Data
apus stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
apus competitorsAPUS
ANTX
IGC
MIRA
MLSS
MYOStock Performance
Full HistoryAbout Apimeds Pharmaceuticals US, Inc
Apimeds Pharmaceuticals US, Inc (APUS) functions as a clinical-stage biopharmaceutical firm operating within the United States. This company is dedicated to the entire lifecycle of its flagship produ…
what is apimeds pharmaceuticals us, inc · apus stock overview · apimeds pharmaceuticals us, inc company profile · who is apimeds pharmaceuticals us, inc ceo · apus AMEX · apimeds pharmaceuticals us, inc headquarters · apimeds pharmaceuticals us, inc business segments
About Stock Overview & Key Data
Apimeds Pharmaceuticals US, Inc (APUS) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on AMEX since May 9, 2025. As of the latest trading session, APUS stock price is $1.13, with a market capitalization of $1.4M. The stock has returned -31.91% over the past 12 months and -21.95% year-to-date.
In fiscal year 2025, Apimeds Pharmaceuticals US, Inc reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Apimeds Pharmaceuticals US, Inc (APUS) stock price is $1.13. The stock is traded on AMEX under the ticker symbol APUS. The 52-week range is $1.17 – $40.31.